United States
Germany
Japan
United Kingdom
China
Map2k2 (Myc-DDK-tagged) - Mouse mitogen-activated protein kinase kinase 2 (Map2k2)
| Type | Mouse Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
Map2k2 - KN2.0, Mouse gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Map2k2 (Myc-DDK-tagged ORF) - Rat mitogen activated protein kinase kinase 2 (Map2k2), (10 ug)
| Type | Rat Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Map2k2 (tGFP-tagged) - Mouse mitogen-activated protein kinase kinase 2 (Map2k2), (10ug)
| Type | Mouse Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Lenti ORF clone of Map2k2 (mGFP-tagged ORF) - Rat mitogen activated protein kinase kinase 2 (Map2k2), (10 ug)
| Type | Rat Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Map2k2 (Myc-DDK-tagged ORF) - Rat mitogen activated protein kinase kinase 2 (Map2k2), (10 ug)
| Type | Rat Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Mutants
Assay Types
Brands
Families
Pathways
- Acute myeloid leukemia (2)
- B cell receptor signaling pathway (2)
- Bladder cancer (2)
- Chronic myeloid leukemia (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc epsilon RI signaling pathway (2)
- Gap junction (2)
- Glioma (2)
- GnRH signaling pathway (2)
- Insulin signaling pathway (2)
- Long-term depression (2)
- Long-term potentiation (2)
- MAPK signaling pathway (2)
- Melanogenesis (2)
- Melanoma (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Non-small cell lung cancer (2)
- Pathways in cancer (2)
- Prion diseases (2)
- Prostate cancer (2)
- Regulation of actin cytoskeleton (2)
- Renal cell carcinoma (2)
- T cell receptor signaling pathway (2)
- Thyroid cancer (2)
- Toll-like receptor signaling pathway (2)
- VEGF signaling pathway (2)
- Vascular smooth muscle contraction (2)
